Introduction
Osteoarthritis (OA) is a degenerative joint disease that affects millions of people worldwide. In the USA alone, OA affects 37% of adults over 65 years old. [1] The disease is characterised by progressive loss of hyaline cartilage in the synovial joints which leads to significant joint pain, swelling and stiffness for sufferers. The disease is also a significant economic burden with associated costs estimated to range from $3.4-13.2 billion per year in the USA. [2] The current gold standard treatment option for OA is total joint arthroplasty where the diseased cartilage and underlying bone are replaced with a metal and polymer prosthesis. While the procedure is well established failures and complications are not uncommon. [3, 4] For example, ten year revision rates of up to 12% have been reported. [5] This has led to an increased interest in the field of cartilage and osteochondral tissue engineering (TE) where de novo tissues can be engineered to facilitate joint regeneration and hopefully prevent the onset of OA.
Significant progress has been made in the field of TE over the last two decades with numerous studies demonstrating how combinations of biomaterials, cells and bioactive factors can be used to engineer de novo cartilage and bone in vitro and in vivo. [6] [7] [8] [9] [10] [11] In the case of cartilage tissue engineering this has classically involved encapsulating chondrocytes, or stem cells which can be differentiated along a chondrogenic linage, in a supportive matrix such as a hydrogel or scaffold. The efficacy of such approaches for treating focal cartilage or osteochondral defects has been demonstrated by a number of groups in large animal models. [12] [13] [14] [15] [16] [17] [18] In addition, a number of chondrocyte based therapies such as MACI (autologous cultured chondrocytes on porcine collagen membrane) are available clinically and newer tissue engineered cartilage products have entered the clinical trial stage, with some demonstrating improvements in defect healing compared to existing treatment options such as microfracture or autologous chondrocyte implantation. [19] However, many products have also failed to demonstrate efficacy and challenges remain in translating TE technologies into the clinic. [19] Furthermore, existing approaches are designed to repair focal cartilage defects, but are not suitable for treating osteoarthritic joints. The majority of TE products are typically Significant progress has been made in the field of cartilage and bone tissue engineering over the last two decades. As a result, there is real promise that strategies to regenerate rather than replace damaged or diseased bones and joints will one day reach the clinic however, a number of major challenges must still be addressed before this becomes a reality. These include vascularization in the context of large bone defect repair, engineering complex gradients for bone-soft tissue interface regeneration and recapitulating the stratified zonal architecture present in many adult tissues such as articular cartilage. Tissue engineered constructs typically lack such spatial complexity in cell types and tissue organization, which may explain their relatively limited success to date. This has led to increased interest in bioprinting technologies in the field of musculoskeletal tissue engineering. The additive, layer by layer nature of such biofabrication strategies makes it possible to generate zonal distributions of cells, matrix and bioactive cues in 3D. The adoption of biofabrication technology in musculoskeletal tissue engineering may therefore make it possible to produce the next generation of biological implants capable of treating a range of conditions. Here, advances in bioprinting for cartilage and osteochondral tissue engineering are reviewed.
www.advancedsciencenews.com www.advhealthmat.de formed using mechanically weak hydrogels or scaffolds and are not suitable for treating the large areas of degenerative joint surfaces associated with diseases such as OA. It is evident that a new generation of more sophisticated tissue engineered cartilage and osteochondral grafts are required to treat this more challenging patient population. TE strategies typically aim to homogenously distribute biological factors such as cells and growth factors throughout a biomaterial matrix. As a result, engineered tissues are often homogenous in composition. However, articular cartilage is a highly anisotropic tissue whose composition and organization varies greatly with depth. The tissue can be divided into three zones, the superficial, middle and deep zone, which are defined by gradients in collagen and proteoglycan content and collagen fiber alignment. [20] [21] [22] [23] [24] [25] [26] These variations in ECM composition and architecture in turn impart zonal biomechanical properties to the tissue. [24, 27] It is generally accepted that further progress in the field will require strategies that can better recapitulate the spatial complexity of the native tissue and its interface with subchondral bone. [6] The next generation of cartilage and osteochondral tissue engineered products should therefore incorporate these considerations. Another major challenge in the field of cartilage TE is that the mechanical properties of tissue engineered cartilage often fall below those of the native tissue. Ideally, tissue engineered cartilage would be able to withstand the high levels of compressive and shear loading that will be present in an articulating joint upon implantation. This is another key consideration for the next generation of tissue engineered cartilage products, especially those designed to treat joints with large areas of degeneration.
The aforementioned issues have led to an increased interest in the use of biofabrication for cartilage and osteochondral tissue engineering as the additive, layer-by-layer technology makes it possible to spatially pattern cells, bioactive factors and biomaterials in 3D. [28] [29] [30] [31] For example, polymer reinforced hydrogels with mechanical properties approaching those of native cartilage can be printed using multi-tool biofabrication. [32, 33] In addition, bioprinting technology can be used to engineer zonally organized constructs with gradients of cells and biological cues. [34] In this review we will discuss developments in bioprinting for cartilage tissue engineering. In addition, since damaged or diseased articular cartilage is also commonly associated with defects or degeneration of the underlying subchondral bone, we will also review developments in bioprinting for bone tissue engineering and how the technology can be used to engineer osteochondral implants. Finally, we will discuss some potential future directions for the field and how biofabrication technologies could be used to develop the next generation of cartilage and osteochondral grafts suitable for treating challenging joint defects and potentially osteoarthritic joints.
3D Bioprinting in Cartilage and Bone Tissue Engineering

General Bioprinting Hardware for Tissue Engineering
A number of groups have started to explore the use of microextrusion and inkjet based bioprinting of cell laden hydrogels for cartilage tissue engineering (CTE) and bone tissue engineering (BTE). Microextrusion is a widely used technique where bioink strands are extruded through a nozzle, onto a substrate, from a pressurised syringe barrel. Hydrogels are mainly used as the ink since they can be extruded while supporting a cargo of viable cells, growth factors and/or genetic material. The viscosity of the bioink must be sufficiently high to avoid tension driven droplet formation at the nozzle tip for extrusion of continues filaments. In an early approach, chondrocytes were extruded into simple geometries using a hyaluronic acid and dextran based hydrogel. [35] The authors observed high cell viability for up to 3 days in vitro demonstrating the promise of such approaches. In another early approach, chondrocytes were encapsulated in gelatin metacrylamide (GelMA) hydrogels and extruded into simple porous grid structures for CTE. [36] The cells were cultured for 4 weeks in vitro and deposited sGAG and collagen type II within the printed constructs. Droplet based bioprinting has also been explored for CTE. Droplet bioprinting systems deposit discrete volumes of bioink during translation rather than the continuous strands produced during microextrusion. These droplets can be generated by using either inkjet, [37] [38] [39] [40] micro-valve, [41, 42] or acoustic droplet [43] [44] [45] technology. In an early proof-of-principal approach, human articular chondrocytes were encapsulated in a poly(ethylene) glycol dimethacrylate (PEGDMA) bioink and inkjet printer to create 3D tissue constructs (Figure 1a) . [46] This study demonstrated that chondrocytes were viable and capable of synthesising cartilage matrix components postprinting. In another study, the same authors demonstrated how it was possible to leverage the process to directly print into a cartilage defect. [47] Matrix formation was assessed after six weeks and despite a visible interface between the native
Adv. Healthcare Mater. 2017, 6, 1700298 Figure 1 . Applications of biofabrication technology in cartilage tissue engineering. a) Direct inkjet bioprinting of chondrocytes loaded in a photo-curable PEGMA bioink into a chondral defect. Reproduced with permission. [50] Copyright 2012, Mary Ann Liebert. b) Biofabrication of osteochondral tissue equivalents where microextrusion bioprinting was used to create a bi-layered construct containing chondrocytes in the cartilage layer and osteoprogenitors in the bone layer. Distinctive tissue formation was observed in the system in vivo as demonstrated by localised ALP staining in the bone region and collagen IV in the cartilage region. Reproduced with permission. [51] Copyright 2012, Mary Ann Liebert. c) Bioprinting of complex shaped cartilaginous tissues using clinically compliant biomaterials. The bioink was composed of two FDA compliant polysaccharides (alginate, gellan) and combined with clinically available cartilage derived particles. a-f) Using patient specific data, anatomically accurate, auricular shaped constructs containing overhanging layers could be printed with the ink. g-j) The process could be leveraged to printed meniscal shaped constructs that could be manipulated by surgeons and sutured into a focal meniscal defect. k-m) The system could also be used to print tissue templates in the geometry of the intervertebral disc and nose, further demonstrating the versatility of the approach. Reproduced with permission. [52] www.advancedsciencenews.com www.advhealthmat.de and repaired cartilage, the interface failure stress had significantly increased with time, demonstrating the potential of this approach. In another early approach for bone tissue engineering, inkjet bioprinting was used to spatially pattern bone morphogenetic protein (BMP)-2 in order to locally direct adult stem cells along osteogenic and myogenic lineages. [39] For more detailed information on microextrusion and inkjet bioprinting, the reader is directed to a number of excellent reviews on this topic. [30, 48, 49] 
General Bioink Requirements
A wide range of bioinks, with suitable rheological behaviour, have been developed for microextrusion and inkjet bioprinting. For example, alginate, [53] [54] [55] [56] GelMA, [57, 58] agarose, [59, 60] collagen, [61, 62] fibrin, [63] [64] [65] silk, [66] [67] [68] forms of poly(ethylene) glycol (PEG) [69] [70] [71] and hyaluronic acid [72, 73] have all been shown to be compatible with such bioprinting technology. A number of criteria must be met when developing bioinks for microextrusion. First, the bioink must have suitable rheological properties for controlled microextrusion, and second, it must also be capable of supporting cell growth and tissue development post-printing. Developing bioinks that can satisfy these two requirements is challenging. Cells benefit from lower polymer concentrations and cross linking densities where they can more readily proliferate and differentiate toward a target tissue. [74] [75] [76] However, higher polymer concentrations often result in hydrogels with suitable rheological behaviour for extrusion as the viscosity is increased. In addition, higher polymer concentrations are typically associated with improved mechanical properties. These opposing requirements form what has been coined the biofabrication window. [77] The most important rheological parameters to consider when designing bioinks are viscosity, yield stress and shear thinning behaviour. [77] Higher polymer densities are more suitable for microextrusion since they are more viscous and possess a higher yield stress. However, it should be noted that higher viscosity inks, along with higher extrusion pressures and smaller diameter nozzles, increase shear forces experienced by cells during extrusion, which can lead to cell death. [78, 79] For example, shear stresses greater than 60 kPa have been shown to kill greater than 35% of cells during microextrusion. [80] As a result, the resolution of microextrusion based bioprinting is limited by shear induced cell death. Typically filament diameters of 150-2000 µm can be achieved by controlling the bioink viscosity, extrusion pressure and nozzle diameter. [57, 79, 81] The lowest resolution nozzle typically used for microextrusion of cells is 30 Gauge (159 µm diameter). The needle geometry can also be controlled to reduce shear forces experienced by cells during extrusion. [57] For example, at lower inlet pressures cell viability can be increased by using conical rather than cylindrical needles. Interestingly however, at higher inlet pressures conical needles supported lower cell viability. The authors hypothesised that both the magnitude of shear stress along with the exposure time to the shear stress are important. For more general information on bioink development the reader is directed to a number of excellent reviews. [77, 82, 83] 
Cartilage Tissue Engineering (CTE)
Bioink Development for Cartilage Tissue Engineering
A number of different bioinks have been explored for CTE. In an early study, it was demonstrated how bioprinting technology could be used to engineer osteochondral tissue constructs using an alginate bioink. [51] Bi-layered implants were printed with chondrocytes encapsulated in the cartilage layer and osteogenic progenitors encapsulated in the bone layer (Figure 1b) . Distinctive tissue formation was observed both in vitro and in vivo using this system. Cartilage matrix components such as hyaluronic acid and chondroitin sulphate can be combined with alginate to create more biomimetic hydrogels capable of supporting superior neocartilage formation. [84] GelMA has also been shown to support cartilage tissue formation using chondrocytes and MSCs, [36] although this bioink appears to support the development of a more fibrocartilaginous type tissue with higher levels of collagen type I production. [85] Again however, the addition of hyaluronic acid and chondroitin sulphate to GelMA can enhance chondrogenesis. [36, 86] In addition, the incorporation of these components has the added benefit of increasing the bioink viscosity which can enhance printability. [36] In a similar approach, a synthetic thermosensitive hydrogel composed of a base methacrylated polyHPMA-lac-PEG triblock copolymer was chemically combined with either methacrylated chondroitin sulphate (CSMA) or methacrylated hyaluronic acid (HAMA) for cartilage bioprinting. [87] Novel shear thinning bioinks have also been developed for CTE by combining alginate and nanofibrillated cellulose. [88] These inks are highly printable, capable of supporting cell proliferation and the subsequent synthesis of cartilage matrix components. [88, 89] The chondrogenic capacity of these inks can also be enhanced by sulphating the alginate component. [89] The sulfation of the alginate has been shown to maintain the phenotype of chondrocytes through activation of FGF (Fibroblastic Growth Factor) signaling. [90] However, care must be taken when utilizing nanocellulose as a thickening agent. The resultant inks are highly viscous and it has been demonstrated that after extrusion through smaller diameter nozzles, excess shear stress can cause chondrocytes to lose their capacity for proliferation and synthesis of ECM components. [89] Recently, a number of groups have started to explore the use of extracellular matrix (ECM) based bioinks. [52, 91, 92, 93] It is believed that the incorporation of tissue specific ECM components into a bioink can provide environments more conducive to supporting specific cellular phenotypes. In one example, heart, fat and cartilage tissue were first decellularised and then solubilised at neutral pH at 4 °C to create an extrudable thermosensitive bioink. [91] The solubilised ECM bioink could be stored at 4 °C in an extrudable form. Postprinting, the bioink filaments could be solidified by raising the temperature to 37 °C. It was found that the encapsulated cells remained viable post-printing and were capable of differentiating toward the lineage specific to the ECM used to form the ink. It was also possible to deposit the bioink within a polymeric framework to generate three dimensional tissue templates. An identical approach has been used by the same authors using a skeletal muscle derived bioink, further www.advancedsciencenews.com www.advhealthmat.de demonstrating the versatility of the approach. [92] In another study, a chondroinductive bioink was developed by combining gellan, alginate and cartilage ECM particles. [52] Highly accurate anatomical shapes could be printed with the ink and chondrocytes were capable of proliferating and producing matrix components within it (Figure 1c) . In a novel scaffoldfree bioprinting approach, modular cartilage tissue strands, which were fabricated by fusing tissue spheroids in a confining mold, were capable of being printed into 3D constructs using a robotic dispensing system. [94] A summary of bioinks used in CTE to date is provided in Table 1 below.
Bioprinting of Heterogeneous Cartilage Tissues
Recently, a number of studies have explored whether bioprinting can be used to engineer cartilage tissues with regional distinctions in their composition. Spatially heterogeneous, anatomically shaped constructs have been bioprinted using a high density collagen bioink for CTE. [61] The constructs were able to support cell growth and it was possible to spatially localise two different cell populations. In addition, it was also possible to modulate the regional mechanical properties of the construct by varying the bioink density. This is an important consideration for CTE as the stiffness of the underlying substrate can influence the chondrogenic capacity of MSCs, with stiffer matrices supporting a more transient hypertrophic phenotype. [75] As mentioned previously, the composition of articular cartilage varies greatly with depth. In an attempt to recapitulate this structure, Ren et al. bioprinted a density gradient of chondrocytes in a single construct using a collagen type II bioink. [34] The cell density gradient resulted in a graded distribution of ECM components, demonstrating the promise of such biomimetic approaches. A wide range of alternative approaches could be explored in order to engineer zonally organized cartilage tissues using bioprinting technology. These will be further discussed in Section 3.1.2.
Bioprinting in Bone Tissue Engineering (BTE)
Osteoarthritis is a disease that can affect both the articular cartilage and the underlying subchondral bone. Furthermore, traumatic joint defects often penetrate or progress into the underlying subchondral bone. As a result, there has been a significant amount of research devoted to developing implants for osteochondral defect repair. Many of the bioprinting technologies which have been described above for CTE have also been widely used for BTE. This section will describe the key developments in bioprinting and bioinks for BTE.
Adv. Healthcare Mater. 2017, 6, 1700298 [85] Chondro-permissive 1 (Challenging to print high aspect ratios without supporting structures) Alginate [85, 95] Chondro-permissive 2 (requires smart cross-linking approaches/thickening agents to print higher shape fidelity constructs) [53, 95, 96] Sulphated Alginate [90] Chondro-inductive (can bind growth factors such as fibroblast growth factor (FGF), transforming growth factor (TGF) and induces potent proliferation and collagen II deposition by encapsulated bovine chondrocytes 2 (requires smart cross-linking approaches to print higher shape fidelity constructs)
Alginate/Nano-cellulose [89] Chondro-permissive 3 (nanocellulose imparts shear thinning behaviour) GelMA [85, 97] Chondro-permissive 2 (requires smart cross-linking approaches to print higher shape fidelity constructs) [57, 72] Hyaluronic Acid [36, 84, 98] Chondro-inductive 2
GelMA + (hyaluronic acid) [36] Chondro-inductive (Addition of HA enhances chondrogenesis) 2 (Addition of HA enhances rheological behaviour)
GelMA/Gellan Gum [81, 97] Chondro-permissive (Addition of gellan gum does not enhance chondrogenesis compared to GelMA alone) 3 (addition of gellan gum imparts shear thinning behaviour)
PEGDMA (poly(ethylene) glycol dimethacrylate) [85] Chondro-permissive 2 (requires smart cross-linking approaches/thickening agents to print high shape fidelity constructs) [72] Collagen [61] Chondro-permissive 2 (Requires high collagen densities for controlled extrusion ≈15 mg ml
Fibrin [99] Chondro-permissive 1 (requires smart cross-linking approaches/thickening agents to print higher shape fidelity constructs) [100] Methacrylated Poly[N-(2-hydroxypropyl) methacrylamide mono/dilactate]-PEG Triblock [87] Chondro-inductive (Incorporates methacrylated chondroitin sulphate (CSMA) or methacrylated hyaluronic acid (HAMA) to support chondrogenesis 2 Scoring system, Chondrogenic capacity = chondro-inductive, refers to a biomaterial that has been shown to directly promote chondrogenesis. Chondrogenic capacity = chondro-permissive, refers to a biomaterial that has been shown to support chondrogenesis when coupled with an external stimulus such as a chondrogenic growth factor. Inherent printability = 1, defines a material that cannot be extruded in a reliable fashion for more than 1 layer with ease. Inherent printability = 2, defines a material that can be extruded into relatively simple shapes. Inherent printability = 3, defines a material that can be extruded into complex shapes with overhanging structures.
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Developing Bioinks for Bone Tissue Engineering
One of the most common natural materials used for hydrogel based BTE constructs is alginate. [101, 102] As discussed previously, alginate is commonly used as a bioink, making it a promising candidate for bioprinting implants for bone regeneration. [103, 104] For example, when implanted in conjunction with BMP-2, bioprinted alginate constructs can promote bone formation after 12 weeks in vivo. [104] However, these studies used a high molecular weight alginate which is easier to print with as it has a higher viscosity than other molecular weight alginates. This increase in molecular weight also significantly decreases its degradability, which is a key consideration for BTE. Both studies saw significant amount of alginate still present after 12 weeks in vivo. Moreover, there was no tissue formation or vessel infiltration within the gel itself, only in the surrounding area. Other studies using alginate based constructs for bone regeneration have reported similar problems. [105] [106] [107] [108] This motivates the development of lower molecular weight alginate bioinks with faster degradation rates for BTE applications. [108] In general, the leading limitation to the use of hydrogels alone for bone regeneration is their limited osteoinductivity and poor mechanical properties. This has motivated the development of composite bioinks with enhanced mechanical properties and osteo-inductivity. Wang et al. found that a bioink of both gelatin and alginate seeded with human adipose derived stem cells could induce bone matrix formation when subcutaneously implanted for 8 weeks in nude mice. [109] Another study created a methacrylated gelatin bioink with encapsulated bone marrow MSCs and collagen microfibers bound to BMP-2. When compared to a bioink encapsulated with bone marrow MSCs alone and cultured in osteogenic medium, the bioink with bone marrow MSCs and BMP-2 bound collagen microfibers induced faster osteogenesis of MSCs compared to those cultured in the presence of osteogenic growth factors after 14 days in vitro. [110] Campos et al. investigated a composite bioink of collagen and agarose, and found that by combining the thermos-responsive agarose hydrogels with collagen type 1, the mechanical stiffness significantly improved compared to collagen type 1 alone. [111] Other studies have looked into adding bioglass particles to increase the mechanical stability of the hydrogel. [112, 113] These studies have found that the addition of the bioglass can significantly improve the mechanical properties of the bioink [113] whilst also producing a printable, porous material that can be used for generating BTE scaffolds. [112, 113] Micro-carriers or small particles (100-400 µm) of polymers such as PLA (poly(lactic) acid) or polyethylene have also been shown to increase the mechanical strength of a hydrogel. [114, 115] Leveto et al. investigated the effect that adding micro-carriers to GelMA had on the mechanical properties of the hydrogel. This enhanced the mechanical properties of the construct and the differentiation potential of human MSCs was also improved. [116] Wüst et al. investigated a combination of gelatin, alginate, and hydroxyapatite and found that the Young's modulus was significantly increased if 8% hydroxyapatite was added to the hydrogel. [117] However, even with a composite hydrogel the natural based hydrogels will still have a relatively low stiffness, in the kPa range, compared to bone which is in the GPa range.
Other investigators have explored the use of synthetic polymers within bioinks for BTE applications. Inkjet printing GelMA with added PEG significantly improved the resultant mechanical properties compared to GelMA constructs alone. Other studies investigated the addition of hydroxyapatite within a gelatin [118] and polymer [119] based bioink to increase the mechanical properties of printed scaffolds. These studies found that the mechanical properties of such scaffolds increased to within the range of trabecular bone of the same density (3.8-4 MPa). Although these printed constructs have improved mechanical properties, they are still lower than scaffolds produced using other rapid prototyping strategies such as fused deposition modelling (FDM). PLGA-PEG-PLGA, [120] PLGA alone, [121] PLA alone, [122] PCL alone, [123] and PCL-PLGA-TCP [124] printed constructs have also been shown to have increased stiffness with moduli within the range of 57.4-244 MPa respectively, which is closer to the range for cortical bone. [125, 126] This had led to increased interest in strategies where FDM can be integrated with microextrusion bioprinting to engineer composite reinforced tissues for BTE. This will be discussed in Section 2.3.
Bioprinting and Vascularisation in Bone Tissue Engineering
Ensuring the successful vascularisation of TE constructs is arguably the most challenging hurdle to overcome in the field of BTE today. [127] As a result, there has been increased interest in using bioprinting technology to accelerate vascularisation of tissue engineered constructs for BTE. For example, a number of studies have explored the importance of the architecture of TE constructs on vascularisation and subsequent bone formation in vivo. [56, 103, 128] For example, it has been demonstrated that the incorporation of microchannels into MSC seeded alginate hydrogels, achieved using bioprinting technology, could enhance vessel infiltration compared to a solid non-porous controls after 14 days in vivo. [103] Other studies, have used bioprinting to allow for spatial presentation of specific growth factors to enhance angiogenesis. Park et al. printed a PCL fiber based construct, with dental pulp stem cells and BMP-2 encapsulated in type 1 collagen deposited on the periphery, and a composite of gelatin and alginate with VEGF deposited in the center (Figure 2a) . Microvessels were newly formed in the center of the printed construct, with angiogenesis from the host tissue was also observed. Interestingly, vascularisation was enhanced by localizing VEGF presentation to central regions of the construct (Figure 2b) . In another study, hierarchical vascularised bone biphasic constructs were bioprinted using a novel dual bioprinting approach. [129] Regional localisation of VEGF and BMP-2 was achieved using a novel thiol-ene click reaction which resulted in formation of a vascular network within the implant. In another approach, it was demonstrated that bioprinted scaffolds that facilitated the sustained long-term release of VEGF from a matrigel/alginate bioink could be used to enhance vascularisation in vivo. [130] 
Bioprinting of Composite Reinforced Tissues
One of the major limitations with using hydrogel based bioinks is that they are often mechanically weak, and alone www.advancedsciencenews.com www.advhealthmat.de
are not capable of supporting loading within a joint environment. To overcome this limitation, multi-material bioprinting approaches have been developed where a "soft" bioink can be reinforced with "stiffer" biocompatible and biodegradable polymer. [32, 33, 54, 85, 100, 132] The most common approach is to coextrude a stiff thermoplastic polymer such as PCL using FDM, alongside a bioink containing cells using microextrusion bioprinting. [32, 56, 65] In this section we will first introduce fused deposition modelling. Next, this will be followed by a description of how the technology can be integrated with microextrusion bioprinting to engineer composite reinforced tissues for CTE and BTE.
Fused Deposition Modelling (FDM)
FDM is an additive manufacturing technology used for production, prototyping and modelling applications. As cells cannot be incorporated during the printing process due to high processing temperatures FDM is not technically considered bioprinting, however it is commonly used for producing porous scaffolds for TE. [133] FDM printers use a thermoplastic filament which is heated above its melting point and extruded onto a platform in a layer-by-layer process. The key advantage of FDM is that scaffolds with highly interconnected pore geometries and channels sizes can be fabricated rapidly. By varying process parameters such as the extrusion pressure, nozzle dia meter and deposition speed it is possible to print scaffolds with a wide range of filament diameters and porosities. [134, 135] Another key advantage of these scaffolds is that they are mechanically strong, possessing mechanical properties in the range of articular cartilage and cancellous bone. [25, [134] [135] [136] [137] [138] FDM in Cartilage and Osteochondral Tissue Engineering: In one of the earliest applications of biofabrication technology in CTE, porous scaffolds were fabricated from a poly(ethylene glycol)-terephthalate poly(butylene terephthalate) (PEGT/PBT) block co-polymer using FDM. [139] Scaffolds with varying pore geometries were seeded with bovine articular chondrocytes and shown to support robust cell proliferation and matrix synthesis. The same group also compared scaffolds generated with FDM to more traditional particulate leached scaffolds. [140] Cell viability in central regions of the scaffold produced via FDM was significantly higher than the controls, with the authors demonstrating this was due to superior nutrient and oxygen diffusion in the orientated pores of the FDM scaffold. In another early approach, a biphasic osteochondral scaffold composed of a PCL-TCP phase for the bone region, and a PCL-fibrin phase for the cartilage phase was generated using FDM. [141] The scaffolds were seeded with bone marrow derived MSCs and implanted into osteochondral defects in rabbits. Post-implantation, µCT analysis revealed significant regeneration in the bone phase, however, cartilage repair was limited throughout. Porous PEOT/PBT scaffolds produced using FDM and seeded with MSCs have also been explored for osteochondral defect Reproduced with permission. [131] Copyright 2015, Royal Society of Chemistry.
www.advancedsciencenews.com www.advhealthmat.de repair. [142] Compared to empty controls, no significant improvement in repair was observed highlighting the challenges faced in regenerating cartilage defects. Recently, more sophisticated approaches have been developed in an attempt to develop spatially graded cartilage tissues, with architectures better mimicking the native tissue. For example, gradients in pore size, pore geometry, surface energy and stiffness can be tuned using FDM resulting in improved MSC chondrogenesis in vitro. [143] [144] [145] It is yet to be seen whether these improvements in vitro will translate into enhanced cartilage defect repair in vivo.
FDM in Bone Tissue
Engineering: 3D printing of synthetic polymers also represents a promising material for bone tissue repair as they provide the necessary mechanical strength, are easy to fabricate, are cost effective, biocompatible and have tuneable degradation rates. The most common synthetic polymer used for printed BTE scaffolds is PCL [146, 147] and PLGA, [121, 148] with both shown to support bone regeneration. [149] However, although such synthetic polymers generate mechanically stable constructs, they do not contain osteoconductive factors such as tri-calcium phosphates (TCP) and hydroxyapatite (HA). Taking this into account, more recent studies have begun to investigate the potential of 3D printed composite structures with filaments consisting of both osteoconductive ceramics and synthetic polymers. [150] [151] [152] Heo et al. investigated the regeneration potential of a printed nHA/PCL composite scaffold within a rabbit tibial segmental defect model. After 8 weeks, dense bone tissue formation was observed throughout all of the constructs. [150] However, although dense bone had formed in and around the scaffold a large proportion of the scaffold was still present after 8 weeks in vivo. Kim et al. investigated the regeneration potential of TCP coated PLGA constructs within a rabbit femoral defect model. At 12 weeks, the TCP coated constructs showed a trend towards increased bone formation however, new bone formation was <10% across the treatment groups. [151] Finally, Reichert et al. investigated if 3D printed constructs that display similar mechanical properties to cancellous bone might be suitable to augment segmental ovine bone defects of the tibia. PCL-TCP and poly(L-lactide-co-D,L-lactide) (PLDLLA)-TCP-PCL scaffolds were implanted within an ovine segmental defect for 12 weeks. After 12 weeks only minor external callus and bone formation was observed in the scaffold groups, with the least amount of bone formation present within the PCL-TCP composite constructs. [152] In general, the results from these studies show the potential for the use of 3D printed composite constructs for the repair of large segmental defects, however significant room for improvement is noted in many of these studies.
Bioprinting of Reinforced Constructs for Cartilage and Osteochondral Tissue Engineering
It has been shown that PCL and cell containing bioinks can be co-printed in a layer-by-layer fashion to build 3D constructs for CTE (Figure 3a) . [153] Even though the PCL component is heated to approximately 60 °C to facilitate extrusion, cells in the bioink phase remain viable post-printing. [85] The mechanical properties are significantly improved with the incorporation of PCL filaments and by modulating the percentage of reinforcing poly mer, constructs with compressive equilibrium moduli in the range of articular cartilage can be achieved. [85] A subcutaneous analysis of a PCL reinforced alginate construct embedded with chondrocytes and supplemented with chondrogenic growth factor TGF-β3 reported collagen type II and sGAG deposition. [54] In a similar approach, bi-layered constructs with spatially distinct regions of ECM materials and growth factors were created for osteochondral tissue engineering. [154] Human MSCs were combined with atelocollagen and BMP-2 in the bone region, and hyaluronic acid and TGF-β3 in the cartilage region. The construct was reinforced using a PCL frame and demonstrated heterogeneous tissue development in an osteochondral defect model. With such approaches there is little or no mechanical interaction between the reinforcing component and the bioink network. This can be a problem, particularly at higher strains, which can lead to mechanical disintegration of the implant upon the application of mechanical loads. Recently, it has been demonstrated that by covalently crosslinking the hydrogel and thermoplastic phases together it is possible to increase the interface strength. [132] This resulted in improved resistance to repetitive rotational and axial loading. It should be noted here that co-printing approaches can influence the mechanical properties of the final construct. For example, layer-by-layer bioink deposition can interfere with the adhesion of PCL fibers during co-printing which can significantly reduce the resultant mechanical properties of the engineered construct. [155] The degradation rate of PCL, which can be up to 2-3 years, [157, 158] is a potential limitation with such multi-material approaches, as residual filaments can act as a barrier to tissue formation. Recently alternative polymers based on PCL have been developed to overcome these potential limitations. A poly (hydroxymethylglycolide-co-caprolactone) (PHMGCL) polyester which has a greater hydrophilicity than unmodified PCL due to the addition of hydroxyl groups has been developed which loses ≈60% of its initial weight after 3 months in vivo. [147, 159] An extensive review on the use of PCL for additive biomanufacturing and other biomedical applications is available elsewhere. [158] An alternative approach is to use a faster degrading polymer such as PLGA. PLGA co-polymers composed of PLA and Poly(glycolic acid) (PGA) can be developed which degrade more rapidly due to the hydrophilic nature of PGA which facilitates hydrolysis of the polymer backbone. [160] The rate of degradation can be controlled by varying the ratio of lactide and glycolide in the copolymer, with higher percentages of glycolide resulting in accelerated degradation rates. [160] One drawback of using PLGA is that the build-up of acidic by-products that occur following its degradation can cause adverse inflammatory responses. [161, 162] Osteochondral constructs have also been fabricated using a co-printing approach with PLGA rather than PCL. [163] Here, the chondral layer was formed using an alginate bioink combined with cartilage derived ECM and an alginate/hydroxyapatite bioink was used for the osseous layer. Another way to overcome limitations with residual PCL material is to reduce the amount of the reinforcing polymer used by increasing the porosity of the reinforcing phase. This has led to an increased interest in the use of melt-electrowriting (MEW) which is an emerging technology that combines key aspects of melt-electrospinning www.advancedsciencenews.com www.advhealthmat. de and FDM. The process is similar to FDM except that a voltage is applied between the nozzle tip and the printing platform to draw filaments of material from the nozzle tip onto the platform. By carefully controlling the relative motion between the printhead and the collector it is possible to print the fibers with a high degree of accuracy. Highly organized networks of fibers with diameters down to 0.8 µm have been printed with this technology. [164] [165] [166] This is a major advantage over traditional FDM printing where it is difficult to print fibers with diameters lower than 100 µm. MEW has recently been used to reinforce cell laden GelMA hydrogels with highly porous PCL scaffolds (porosity 98%-93%, fiber diameter 19-50 µm). [33] The stiffness Reproduced with permission. [153] Copyright 2014, IOP. B) Hybrid printing of mechanically improved constructs for CTE. The constructs were produced by inkjet bioprinting rabbit chondrocytes in a fibrin collagen bioink onto electrospun PCL microfibers in a layer-by-layer fashion. Reproduced with permission. [99] Copyright 2013, IOP. C) (a) Biofabrication of soft network reinforced constructs for CTE. Graphical representation of MEW device and operating parameters, (b-d) SEM of crosshatch structure produced with 200 µm, 400 µm and 600 µm fiber spacing. Preparation of composite constructs following injection of highly negatively charged sPEG/Hep hydrogels. Reproduced with permission. [156] Copyright 2015, IOP.
www.advancedsciencenews.com www.advhealthmat.de of the resultant composites were within the native cartilage range and importantly the yielding strains (≈25%-40% strain) of the composites were much higher than equivalent scaffolds produced using FDM (≈8%). This is an important consideration for CTE as strains of greater than 10% are repeatedly experienced during locomotion. [167] In addition, cyclic mechanical tests demonstrated that the scaffold could recover after 20 cycles at 20% strain. Composite soft cartilage constructs have also been fabricated by combining PCL microfibers produced using MEW and a highly negatively charged star-shaped poly(ethylene glycol)/heparin hydrogel (sPEG/Hep) [156] (Figure 3c ). The hydrogel network mimicked the function of the cartilage proteoglycan network and the PCL fibers mimicked the function of the cartilage collagen fiber network. The resultant constructs exhibited mechanical anisotropic, nonlinear and viscoelastic behaviour analogous to native cartilage. Other hybrid strategies include incorporating inkjet printing with electrospinning. [99] A PCL electrospun mat was alternated with a fibrin-collagen solution containing chondrocytes for 5 layers until a thickness of 1 mm was reached (Figure 3b ). The fabricated constructs formed a cartilage matrix both in vitro and in vivo as evidenced by the deposition of type II collagen and sGAG.
Bioprinting of Reinforced Constructs for Bone Tissue Engineering
Co-printing approaches have also been explored for BTE. [56, 128] In one approach, a cell laden bioink containing adipose derived stem cells was co-deposited alongside a mixture of PCL and tricalcium phosphate (TCP). [128] The constructs were implanted in cranial defects in rats and demonstrated good integration and evidence of bone repair. In a similar approach, vertebrae shaped constructs were co-printed using PCL and alginate bioink containing MSCs [56] (Figure 4a) . The constructs were chondrogenically primed in vitro and once implanted in vivo, were capable of forming vascularised bone organs via endochondral ossification (Figure 4b) . The study presents a novel biofabrication strategy for engineering whole bone organs by bioprinting developmentally inspired templates with the capacity to undergo endochondral ossification over time following implantation. Rather than trying to print the complex final bone organ, the relatively simple developmental precursor was printed. This concept of bioprinting developmental precursors could also be used to engineer other complex solid organs.
Whole Joint Resurfacing
The majority of TE studies to date have focused on treating focal cartilage and osteochondral defects. However, diseases such as OA affect the entire joint surface. A number of studies have explored using FDM to engineer templates for biological joint resurfacing. Ding et al. (2013) employed a modular approach to engineer tissue specific, biphasic scaffolds for regeneration of the femoral head. First a porous interconnected PCL/Hydroxyapatite scaffold was fabricated using FDM for the osseous phase and combined with a PLGA scaffold for the chondral layer. [168] Autologous chondrocytes and BMSCs were seeded in the chondral and osseous regions respectively with the construct demonstrating histological evidence of specific cartilage and bone matrix formation along with a wellintegrated osteochondral interface following subcutaneous implantation.
CAD/CAM technology has also been used to tissue engineer constructs potentially suitable for whole joint regeneration. Anatomically accurate constructs were generated from µ-CT scans to form mechanically functional scaffolds with a porous internal architecture using FDM. [169] Rabbit chondrocytes were seeded onto the scaffolds and cultured in chondrogenic media for 21 days prior to implantation (Figure 5a ). Tibial and femoral osteotomies were performed, removing the articular surfaces within the knee and the tissue engineered replacements were fixed within the joint. Histological analysis of the joint post-implantation demonstrated a restoration of two congruent articulating surfaces with evidence of bone tissue formation and host integration. However, the repair tissue was mainly fibrous-like throughout, with little evidence of hyaline cartilage development, highlighting the importance of providing the appropriate biological cues in such large defect models. In an important study by Lee et al. (2010) the surface morphology of a rabbit proximal humeral joint was captured using laser scanning and reconstructed by FDM to engineer an anatomically accurate graft using PCL/Hydroxyapatite. [170] The scaffold was infused with TGF-β3 and implanted into the unilateral proximal humeral condyles of skeletally mature rabbits. Remarkably, all animals that received TGF-β3 infused scaffolds resumed weight bearing and locomotion 3-4 weeks after surgery (Figure 5b ). Hyaline-like cartilage was found to cover the entire surface of the infused scaffolds, with regeneration of a well vascularised subchondral bone region. Importantly compressive and shear moduli of the regenerated cartilage were comparable to native articular cartilage. This study demonstrated that the entire articular surface could be regenerated through homing of endogenous cells into a porous interconnected scaffold. The spatial incorporation of bioactive factors within 3D printed constructs is a promising strategy for developing gradients of biological signals. The localised presentation of these signals can make it possible to engineer tissues that better recapitulate the complex architecture of their native counterparts. Recently, this approach has been explored through the embedding of growth factor loaded PLGA microspheres into PCL microfibers for controlled release, resulting in enhanced regeneration of temporomandibular joint defects. [171] 
Future Directions
Bioprinting technology first emerged around the beginning of the century and despite significant scientific advances, no clinical translation of a bioprinted product has occurred. Many of the challenges that have limited clinical translation in the broader field of Tissue Engineering are also relevant to bioprinting, and the field is in danger of replicating many of the mistakes that were made in the development of tissue engineered products. These include, but are not limited to, the challenge of scalability when developing cell or tissue based www.advancedsciencenews.com www.advhealthmat.de products. For example, human scale prints can take hours to complete depending on the complexity of the fill patterns and materials used. This may not be an issue for bioprinting one-off, patient specific implants, but challenges larger scale production of biological implants. In addition, navigating regulatory pathway and the development of viable business models should also be carefully considered as both have challenged the clinical translation of tissue engineered products. Furthermore, the scientific advantages that can be achieved with the adoption of bioprinting technology must be sufficient to justify the added complexities that will be subsequently encountered when attempting to translate a product. On the other hand, automation of the fabrication process will help smoothing the transition into an industrial setting as minimal operator handling will be required.
It can be argued that many tissue engineered constructs that have been bioprinted for cartilage and bone tissue engineering could have been fabricated using more traditional manufacturing processes such as molding. In addition, many of the studies that have been performed to-date have been "proof of principle" and have generally focused on developing bioinks for cartilage and bone repair. A number of novel bioinks have been developed that push the boundaries of the traditional biofabrication window. These inks are highly printable, but also biologically relevant, and can support cell proliferation, differentiation and tissue production. [89, 52] The next step is to demonstrate that these scientific developments can lead to improved treatment options for bone and cartilage defects. Although bioprinting technology makes it possible to engineer complexities otherwise unattainable with subtractive A) Co-deposition process where alternating filaments of MSC laden bioink and PCL were deposited to build a reinforced bioink containing an array of bioink-free microchannels. B) Development of vascularized bone organ in vivo following implantation of cartilage rudiment. Reproduced with permission. [56] www.advancedsciencenews.com www.advhealthmat.de manufacturing techniques, a limited number of studies have actually taken advantage of this fact. This should be a key area of future research for the field.
However, it should be noted that the field is still relatively young, and in time, we believe the technology will have a key role to play for a number of reasons. Firstly, bones and joints Adv. Healthcare Mater. 2017, 6, 1700298 Figure 5 . Biofabrication as a tool for joint resurfacing. A) Tissue engineered cartilage templates for joint replacement were produced by seeding chondrocytes onto tibial shaped scaffolds, generated using FDM and particulate leaching. Reproduced with permissio Pre-implantation, (c, d) SEM analysis, (e, f) Safranin-O/live-dead analysis and (g, h) immunohistochemical staining for collagen I, II demonstrated robust chondrogenesis within both systems. However, compared to particulate leaching, the scaffolds produced using FDM supported superior cell viability and matrix production in central regions. This is a key consideration when attempting to engineer scaled up implants which will be required for joint resurfacing strategies. Reproduced with permission. [169] B) Regeneration of the articular surface of a rabbit synovial joint using a cell homing approach where bioscaffolds produced using FDM were implanted into the shoulder joint of New Zealand white rabbits following a shoulder joint osteotomy. a-d) Post-implantation, macroscopic imaging demonstrated the addition of TGF-β3 improved cartilage regeneration compared to empty scaffold only controls. e-k) Quantification of the matrix density, cartilage thickness and number of cells/mm 2 following histological staining further demonstrated superior restoration of the articular surface in the joint with the addition of TGF-β3. Reproduced with permission. [170] Copyright 2010, Elsevier.
www.advancedsciencenews.com www.advhealthmat.de are highly challenging mechanical environments and implants are exposed to high levels of shear, compressive and tensile loading. As a result, composite constructs that possess biomimetic mechanical behaviour will likely be required for applications such as biological joint resurfacing. The adoption of biofabrication technology has made it possible to engineer implants with more biomimetic mechanical properties. [33, 156] Another major challenge in the field is that tissue engineered cartilage is often homogenous in nature, lacking the zonal complexity of the native tissue which is crucial for maintenance of joint homeostasis. Here again, bioprinting technology offers clear advantages over more traditional fabrication techniques due to its additive nature. Finally, for joint resurfacing, anatomically shaped, patient specific implants will likely be required. Although molding techniques can be used create anatomical implants for joint repair, [172, 173] it is challenging to pattern cells and/or biomolecules within anatomical geometries using these techniques. This can be achieved using bioprinting technology. Finally, in terms of enhancing vascularisation for bone tissue engineering, bioprinting has received increased interest as the use of fugitive inks make it possible to engineer thick vascularised tissues. [174] This will be a key requirement for joint resurfacing approaches where large volumes of bone will be removed to replace the damaged joint. In this section we will elaborate further on these points and discuss some potential future directions for the field.
Cartilage Tissue Engineering
Biofabrication of Mechanically Functional Cartilage Tissues
Since bioinks are often hydrogel based they are generally mechanically weak and not suitable for deployment in load bearing locations. While significant mechanical reinforcement can be achieved by co-printing thermoplastic polymers, [85] it is not clear whether such implants will be sufficiently tough to withstand long term repetitive loading in a joint environment. For example, scaffolds produced using FDM typically permanently deform at strains levels above 8-10%. [33] In addition, it has been demonstrated that polymer reinforced hydrogels disintegrate at the boundary between the two phases under physiological loads. [132] This problem can be at least partially addressed by improving the interface binding through chemical modification of the materials. [132] However, it is still unclear whether these modifications will be sufficient to withstand repetitive long term loading in a joint environment. Typically, the mechanical properties of tissue engineered cartilage are only measured in compression, and other potential failure modes like shear, are usually ignored. High levels of shear, tension and compression will be experienced in the joint and implants that can withstand repetitive combinations of these loading patterns will be required. Bioreactors models of the joint, that can mimic joint loading patterns, should be used as a checkpoint before attempting to progress into large animal models. [132, 175] Another promising approach to developing mechanically functional implants for joint resurfacing could involve the development of tough bioinks based on interpenetrating network (IPN) hydrogels. IPNs are a class of materials formed by combining multiple polymer networks. By combining a suitably contrasting primary and secondary network that can support IPN entanglement and energy dissipation, it is possible to engineer extremely tough and flexible hydrogels with mechanical properties comparable to high load bearing tissues. [176, 177] Recently, a double network bioink, formed by combining PEG and alginate, was combined with a nano-silicate clay to create a mechanically tough ink with mechanical properties in the range of native articular cartilage. [178] These approaches will likely find utility in the future of cartilage tissue bioprinting. The challenges will arise in balancing the mechanical and biological functionality of the implant as IPN networks are typically dense making it difficult for embedded cell populations to produce de novo matrix components.
Bioprinting of Stratified Cartilage Tissues and Osteochondral Tissue Interfaces
As mentioned previously, articular cartilage is a highly anisotropic tissue and its composition and organization varies greatly with depth. Surprisingly, few studies have explored the possibility of bioprinting gradients of biological factors in order to recreate the zonal properties of articular cartilage and its interface with the underlying bone. Now that a wide range of suitable bioinks are available, future work should explore how combinations of biological cues can be used to engineer biomimetic tissue gradients for CTE. During tissue development, repair and homeostasis cells experience and respond to gradients of chemical and physical cues. These gradients can influence a number of different cellular behaviors including proliferation, migration and differentiation. In a tissue engineering context, physical gradients such as pore size and substrate stiffness, or biochemical gradients such as growth factor presentation, can be introduced into a construct. It has been demonstrated that biochemical gradients, such as the graded presentation of growth factors, can lead to the development of heterogeneous engineered tissues. For example, an overlapping graded presentation of recombinant human bone morphogenic protein 2 (rhBMP-2) and insulin-like growth factor (rhIGF-I) has been shown to direct localized osteogenic and chondrogenic differentiation of MSCs in silk scaffolds. [179] In addition, it has been demonstrated that gradients of TGF-β in MSC seeded hydrogels, which result from a combination of highaffinity binding interactions and a high cellular internalization rate, can lead to the development of highly heterogeneous cartilage tissues. [180] These studies all highlight the benefits of incorporating biochemical and physical gradients into cartilage and osteochondral tissue engineering strategies. Surprisingly, given the additive layer-by-layer nature of biofabrication technology, relatively few studies have explored the possibility of developing gradients using bioprinting approaches. In an early approach, overlapping gradients of IGF-II and BMP-2 have been deposited onto a fibrin substrate and shown to spatially direct the fate of C2C12 cells toward an osteogenic lineage. [181] Future work should look to expand on these approaches to direct the development of both stratified cartilage tissues and the osteochondral www.advancedsciencenews.com www.advhealthmat.de interface. For example, combinations of physical and biochemical gradients could be used to engineer more native like cartilage tissues. As an example of this, a novel dual syringe system was developed to produce a combination of physical and chemical gradients, including substrate stiffness, RGD ligand presentation and growth factor concentration, to control differentiation of MSCs along chondrogenic and osteogenic lineages. [182] In another multifactorial approach, it was demonstrated how combinations of growth factors (BMP-7, IGF-1 and hydroxyapatite), substrate stiffness values (80 KPa, 2.1 MPa and 320 MPa) and nanofiber alignments (horizontal, random, and perpendicular to the gel surface) could be used to direct the zone specific chondrogenic differentiation of MSCs. [183] Bioprinting technology could be used to further expand on these ideas to engineer cartilage tissues with a native like organization. Future advances in bioprinting technology will likely make it possible to present multiple gradients of physical and chemical cues, across multiple length scales. For example, in a recent ground breaking study, a microfluidic bioprinting system capable of simultaneous spatial deposition of 7 distinct bioinks was developed. [184] The system was able to generate complex gradient structures highly suitable for tissue engineering applications. The choice of cell source is also critical for cartilage tissue engineering with chondrocytes and MSCs being the most widely used. [185] An alternative approach could involve bioprinting gradients of cell types/sources in order to engineer stratified cartilage tissues. For example, co culture systems, composed of these cell types, have shown promise in cartilage tissue engineering and could be combined in graded ratios in an attempt to engineer more stratified tissues. [173, 186, 187] Alternatively, zonal specific chondrocytes could be isolated and printed in a layered fashion to recapitulate the depth-dependent properties of the tissue. [21, 188] 
Towards Biofabrication of Anatomically Accurate Osteochondral Tissues
The layer-by-layer nature of bioprinting technology makes it easy to create anatomically accurate constructs for tissue engineering applications. [189] Imaging techniques such as magnetic resonance imaging (MRI) ad computed tomography (CT), that are widely used in the clinic, can be easily converted into formats compatible with biofabrication technology. Patient specific tissue engineered implants could therefore become a reality for sufferers of joints diseases such as OA. However, a number of challenges exist with current bioprinting software that must be addressed. Traditional biofabrication technology creates 3D constructs by continually adding 2D x-y patterns into the z plane. As a result, fibers are orientated parallel to printing platform and the outer surfaces of curved constructs are jagged and discontinuous in nature. This can make it challenging to create constructs with smooth outer surfaces. This is a key consideration for CTE as the main function of the tissue is to support smooth, pain-free articulation. Future work should explore strategies to orientate printed fibers in anatomically relevant orientations. Such capabilities could also lead to more biomimetic mechanical behaviour of resultant tissue engineered implants.
Bioprinting of Vascularized BTE Constructs
As mentioned previously, achieving vascularization is a major challenge for BTE today. [127] The formation of blood vessels involves a complex set of cell-cell interactions. Endothelial cells must proliferate, elongate, undergo lumenogenesis and tubulogenesis and finally become stabilized through the association of pericytes. This process is relatively slow, the average growth rate of newly developing microvessels is only ≈5 µm h −1 , [190] and it also produces networks which are heterogeneous and unpredictable. To improve the efficiency of vascularization in TE tissues, many researchers are now attempting to prevascularize TE constructs to enable rapid anastomosis with host vasculature upon implantation in vivo. Multiple methods have been carried out including establishing microvessel networks within constructs through the self-assembly of endothelial cells in co-culture with supporting cells [191] [192] [193] or electrochemical approaches. [194] Although these approaches can result in a more rapid establishment of a vascular network, the resulting networks are heterogeneous and unpredictable. 3D bioprinting technologies have shown great promise in recent years to overcome these issues by enabling microchannels to be directly fabricated within TE constructs. This enables higher control over the architecture of these vascular networks as well as providing the possibility to design locations for either natural or surgical vascular anastomosis.
One method to pattern perfusable vascular networks is to print sacrificial 3D filament networks within cell permissive hydrogels to create an interconnected vascular template within the construct. [195] Cytocompatible sacrificial materials such as gelatin [196, 197] carbohydrate glass, [195] agarose, [198] and fugitive inks such as pluronic F127 [174, 199] can be easily printed within constructs and later removed to create an embedded hollow network of channels. These channels can be later lined with endothelial cells to create primitive vasculature. [174, 195] Recent advances in direct seeding techniques have shown that vessels as small as 20 µm in diameter can be seeded with endothelial cells. [200] Another more direct approach to achieve controlled vascular networks which is emerging in the field is to directly pattern cells without the need for a subsequent seeding step. Hammer et al. (2014) [201] used a coaxial flow of alginate and calcium chloride solution to fabricate microfibers with sizes ranging 150-200 mm. Cell laden microfibers were encapsulated within 3D hydrogels and then exposed the EDTA to dissolve the alginate microfibers to leave behind microchannels containing cells along the luminal surfaces. In a similar approach, perfusable vascular constructs were created using a direct 3D bioprinting approach. [71] A specially designed bioink consisting of GelMA, alginate and 4-arm poly(-ethylene glycol)-tetra-acrylate (PEGTA) was used in combination with a multi-layered coaxial extrusion system. This made it possible to directly pattern hollow tubes of various diameters containing HUVECs in the lumen of the constructs.
Despite significant progress in bioprinting of vascular networks a number of challenges must still be addressed. Strategies that can direct and connect vascular networks across multiple length scales will be required when attempting to engineer larger bone tissues. The possibility of generating www.advancedsciencenews.com www.advhealthmat.de multiscale vascular networks using 3D bioprinting technology has been demonstrated. [202] Briefly, two larger vessels (≈1 mm lumen diameter) were printed in parallel and surrounded with a HUVEC/fibrin mixture. The larger vessels were next perfused, and over time microvessels self-assembled and integrated with the parent vessels to form a multi scale vascular network. To date, most bioprinting approaches to produce prevascularised constructs involve relatively simple cell combinations. Recent advances in 3D bioprinting techniques are enabling more complex combinations of cell types and biomaterials to be co-printed. This can facilitate the fabrication of multicellular heterogeneous constructs. For example, Colosi et al.
(2016) developed a coaxial needle extrusion system capable of printing two bioinks simultaneously allowing for the deposition of heterogeneous fibers. [203] They demonstrated the ability of this type of approach to produce a 3D HUVEC scaffold capable of supporting beating primary cardiomyocytes. In the future, similar approaches may contribute to the fabrication of rapidly stabilized microvessels through the parallel co-printing of endothelial cells with pericyte-like supporting cells.
The utility of presenting gradients of growth factors has also been demonstrated in the context of angiogenesis. In one example, endothelial cell migration was studied in collagen scaffolds with and without the presence of a VEGF gradient. In the graded presentation ECs migrated and formed sprouted structures, whereas in the controls significantly less sprouting and migration occurred. [204, 205] In the context of TE, neovascularisation within constructs could be further promoted through the incorporation of angiogenic growth factor gradients, either by the direct immobilization of growth factor gradients onto a scaffold [206, 207] or by the inclusion of growth factor containing microspheres within a construct. [179] In combination with bioprinting and biomaterial strategies, which would enable both spatial and temporal control over the delivery of growth factors, future approaches could utilize growth factor gradients to direct the vascularization process.
Engineering the optimal biosignalling, scaffold architecture and cell combination for supporting both angiogenesis and osteogenesis in BTE constructs has yet to be realized. The aforementioned examples demonstrate that bioprinting is a highly adaptable process with great potential to play a significant role in the future of this research.
Bioprinting of Gene Activated Bioinks
The incorporation of bioactive factors within bioprinted implants is a promising strategy for enhanced tissue regeneration. 3D bioprinted constructs can be used as a means to control the release of growth factors to promote lineage-specific differentiation of stem cells, vascularization from the surrounding tissue, and enhanced healing. However, localizing the presentation of signaling molecules can be challenging as hydrogels have diffusive transport characteristics. A potential way to overcome this limitation could be through nucleic acid delivery, via genes encoding for key signaling factors. Nucleic acid delivery allows for a physiological and sustained strategy in which the cell-mediated expression of the transgene guarantees authentic post-translational modifications and increased biological activity. [208] The localised presentation of nucleic acid acids encoding for genes associated with tissue growth and development may be a promising way to engineer complex tissues and interfaces. Additionally, compared to direct growth factor delivery, this strategy allows for a simpler way of simultaneous and sequential delivery of growth and transcription factors that could enhance the multifactorial processes of tissue formation. [209, 210] There are various ways to combine nucleic acid delivery with biofabrication techniques such as 3D printing (Figure 6) . The nucleic acid of interest and its delivery mechanism (chemical, physical or viral) could be incorporated using a one-step approach during the biofabrication process by either its encapsulation into a printable biomaterial, [209, 211, 212] producing a gene activated bioink (GAB) (Figure 6c) , or by the physical introduction of the genetic material into the required cell population due to the forces applied during the printing mechanism [213, 214] (Figure 6b ). Porous bioprinted alginate constructs incorporating plasmid DNA (pDNA) encoding for the osteogenic growth factor BMP2 and calcium phosphate particles were able to efficiently transfect encapsulated MSCs over 14 days and promote their differentiation towards the osteogenic lineage. [211] These gene-activated constructs were also assessed in a goat iliac crest model showing enhanced bone repair. [215] More recently, nanohydroxyapatite-mediated gene delivery in a MSCs laden alginate hydrogel showed to be effective to direct MSC phenotype towards an endochondral or chondrogenic phenotype depending on the delivered genes, [209] confirming the potential of this approach for bioprinting of cartilage and osteochondral tissue interfaces. Inkjet printing was also used for the transfection of primary cells through the transient pores created in the cell membrane during the printing process, [214] achieving a transfection efficiency over 10% and with minimal detrimental effects over cell viability. [213] This promising approach might also allow for a fine spatial control over different transfected cell populations able to reproduce the bio-distribution of growth and transcription factors in native tissues.
In addition, delivery of nucleic acids such as RNA and DNA can be also incorporated into the scaffold after the biofabrication process in a two-step process ( Figure 6 ) through biomaterial-based chemical interactions or direct loading onto the construct, facilitating its cellular uptake. Lentiviral vectors chemically immobilized in 3D orthogonally PCL scaffolds were able to transfect MSCs and drive cell-mediated transforming growth factor beta 3 (TGF-β3) production in a sustained manner over 4 weeks of in vitro culture; [216] the over-expression of the growth factor increased the production of glycosaminoglycans (GAGs) and the expression of the chondrogenic markers aggrecan and collagen type II. [216] 
Engineering Zonally Organized Interface Tissues Using Nucleic Acid Delivery
The development of spatially controlled gene delivery systems in combination with biofabrication techniques could also offer a very tunable strategy for interface TE. The cellmediated expression of the gene of interest could generate precisely controlled gradients of the gene product to enhance www.advancedsciencenews.com www.advhealthmat.de local cell differentiation or maintenance of a desired phenotype (Figure 6d ), avoiding the use of supra-physiological concentrations of recombinant growth factors and associated side-effects. [217] Bi-phasic non-viral gene delivery in an oligo poly(ethylene glycol) fumarate (OPF) scaffold loaded with pDNA encoding for RUNX2 in the osteo layer and for the SOX trio in the chondro layer, showed increased subchondral bone formation in the osteo layer but failed to develop a well-integrated cartilage layer in an rat osteochondral defect model. [218] Spatial distribution of pDNA encoding for either TGF-β1 or
Adv. Healthcare Mater. 2017, 6, 1700298 Figure 6 . Nucleic acid incorporation into 3D bioprinting. A) Two-step incorporation of cells and nucleic acids into porous 3D printed constructs by direct loading. B) One-step incorporation of nucleic acids into the 3D printing process through the introduction of the genetic material into the cell population due to the forces applied during inkjet printing. C) One-step incorporation of nucleic acids into the 3D printing process through the development of gene activated bioinks (GABs). D) Recapitulation of the osteochondral architecture through the spatial deposition of chondrogenic and osteogenic GABs.
www.advancedsciencenews.com www.advhealthmat.de BMP-2 in a MSC-laden, multiphasic collagen-based scaffold showed simultaneous cartilage and subchondral bone regeneration in a rabbit osteochondral defect. [15] Although the described studies highlight the potential of spatial gene delivery for the regeneration of complex interface tissues, 3D bioprinting might solve the limitations of traditional tissue engineering associated with poor layer integration, the scalability of the approach and the tissue organization present in the repair tissue. In addition, more sophisticated patterns of genetic material could be achieved using bioprinting technology in order to recapitulate the body's natural developmental and regenerative pathways.
Conclusions
To realize the ambitious aim of engineering regenerative implants for joint resurfacing a number of challenges must be addressed. Firstly, a candidate implant must be scaled up, anatomically accurate and mechanically functional upon implantation. In addition, the implant must also possess suitable biological activity to initiate repair and/or replace the damaged joint. These challenging requirements make it likely that bioprinting technology will have a key role to play in the future of the field, as the technology can be used to address all of these challenges. Joint resurfacing implants will likely be fabricated using a combination of multiple bioprinting technologies and bioinks in order to mimic the complexity of the native joint. These implants will also likely include spatially defined patterns of cells, proteins and/or genetic material in order to repair and/or replace the damaged joint. If these bioprinted implants promote superior joint regeneration to existing approaches and provide the means to prevent and/or treat diseases such as osteoarthritis, then they will justify attempting to overcome the many regulatory and commercial challenges that will be encountered with clinical transition of bioprinted products.
